Coagulation activators and inhibitors in the neointima of polyester vascular grafts

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 5, 2003, Pages 433-439

  Kowalewski, Radoslaw ^a   Zimnoch, Lech ^a   Wojtukiewicz, Marek Z ^a   Glowinski, Stanislaw ^a   Glowinski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Coagulation activators; Coagulation inhibitors; Endothelium; Immunohistochemistry; Neointima; Vascular graft

Indexed keywords

BLOOD CLOTTING FACTOR 12; POLYESTER; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN ACTIVATION FRAGMENT F1 PLUS 2; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PROSTHESIS; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL GRAFT; DOG; FEMALE; GRAFT OCCLUSION; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOGENICITY;

ANIMALS; AORTA, ABDOMINAL; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BLOOD PROTEINS; BLOOD VESSEL PROSTHESIS; DOGS; FEMALE; HYPERPLASIA; LIPOPROTEINS; MALE; PEPTIDE FRAGMENTS; POLYESTERS; POSTOPERATIVE PERIOD; PROTHROMBIN; THROMBOMODULIN; THROMBOPHILIA; THROMBOPLASTIN; TUNICA INTIMA; WOUND HEALING;

EID: 0042626449     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200307000-00002     Document Type: Article

References (42)

1. Stern DM, Kaiser E, Nawroth PP. Regulation of the coagulation system by vascular endothelial cells. Haemostasis 1988; 18:202-214.
2. Vane JR, Änggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323:27-36.
3. Nemerson Y. Tissue factor and haemostasis. Blood 1988; 71:1-8.
4. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78:747-754.
5. Broze GJ. Tissue factor pathway inhibitor and the revised hypothesis of blood coagulation. Trends Cardiovasc Med 1992; 2:72-77.
6. Dryjski M, Larsson R, Olsson P, Swedenborg J. Effects of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wall. Thromb Res 1983; 32:355-363.
7. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsch J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990; 86:385-391.
8. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264:4743-4746.
9. De Fouw NJ, Haverkate F, Bertina MR, Koopman J, van Wijngaarden A, Hinsbergh VWM. The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood 1986; 67:1189-1192.
10. Glowinski S, Worowski K. The haemostatic system components of neointima forming in polyester aortic grafts in the early postoperative period. Haematologia 1981; 14:393-398.
11. Sato O, Tada Y, Takagi A. The biologic fate of Dacron double velour vascular prostheses - a clinicopathological study. Jpn J Surg 1989; 3:301-311.
12. Boisson C, Jozefonvicz J, Brash JL. Adsorption of thrombin from buffer and modified plasma to polystyrene resins containing sulphonate and sulphamide arginyl methyl ester groups. Biomaterials 1988; 9:47-52.
13. Wilson RS, Marmur A, Cooper SL. A model of deposition and embolization of proteins and platelets on biomaterial surfaces. Ann Biomed Eng 1986; 14:383-400.
14. Stewart GJ, Essa N, Chang KM, Reichle FA. A scanninig and transmission electron microscope study of the luminal coating on Dacron prostheses in the canine thoracic aorta. J Lab Clin Med 1975; 95:208-226.
15. Shi Q, Wu MHD, Hayashida N, Wechazek AR, Clowes AW, Sauvage LR. Proof of fallout endothelialization of impervious Dacron grafts in the aorta and inferior vena cava of the dog. J Vasc Surg 1994; 20:546-557.
16. De Wu MH, Shi Q, Kouchi Y, Onuki Y, Ghali R, Yoshida H, et al. Implant site influence on arterial prosthesis healing: a comparative study with a triple implantation model in the same dog. J Vasc Surg 1997; 25:528-536.
17. Oltrona L, Eisenberg PR, Abendschein DR, Rubin BG. Efficacy of local inhibition of procoagulant activity with small-diameter prosthetic grafts. J Vasc Surg 1996; 24:624-631.
18. Toursarkissian B, Eisenberg PR, Abendschein DR, Rubin BG. Thrombogenicity of small-diameter prosthetic grafts: relative contribution of graft-associated thrombin and factor Xa. J Vasc Surg 1997; 25:730-735.
19. Rubens FD, Labow RS, Meek E, Dudani AK, Ganz PR. Tissue factor expression by cells used for sodding of prosthetic vascular grafts. J Surg Res 1997; 72:22-28.
20. Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 1986; 125:431-435.
21. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Hist Cytochem 1981; 29:577-580.
22. Britton JP, Leveson SH. Distal arterial bypass by composite grafting. Br J Surg 1987; 74:249-251.
23. Woodburn KR, Rumley A, Lowe GD, Love JG, Murray GD, Pollock JG. Clinical, biochemical, and rheologic factors affecting the outcome of infrainguinal bypass grafting. J Vasc Surg 1996; 24:639-646.
24. Glowinski S, Worowski K. Distribution and variation of thromboplastic and fibrinolytic activity of dacron aortic grafts. Cor Vasa 1979; 21:296-303.
25. Lemson SM, Tordoir JHM, Daemen MJAP, Kitslaar PJEHM. Intimal hyperplasia in vascular grafts. Eur J Vasc Surg 2000; 19:336-351.
26. Østerud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. Thromb Haemost 1995; 73:873-875.
27. Schecter AD, Spirn B, Rossikhina M, Giesen PL, Bogdanov V, Fallon JT, et al. Release of active tissue factor by human arterial smooth muscle cells. Circ Res 2000; 87:126-132.
28. Joseph K, Ghebrehiwet B, Peerschke El, Reid KB, Kaplan AP. Identification of the zinc-dependent endothelial cell binding protein for high molecular kininogen and factor XII: identity with receptor that binds to the globular 'heads' of C1q (gC1q-R). Proc Natl Acad Sci USA 1996; 93:8552-8557.
29. Wagner WR, Johnson PL, Heil BV, Thompson KA, Korms RL, Griffith BP. Thrombin activity resides on LVAD Dacron inflow and outflow grafts. ASAIO J 1992; 38:M634-M637.
30. Rubin BG, Toursarkissian B, Petrinec D, Yang LY, Eisenberg PR, Abendschein DR. Preincubation of Dacron graft with recombinant tissue factor inhibitor decreases their thrombogenicity in vivo. J Vasc Surg 1996; 24:865-870.
31. Dittman WA, Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990; 75:329-336.
32. Grinnell BW, Berg DT. Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells. Am J Physiol 1996; 270:H603-H609.
33. Fukudome K, Ye X, Tsuneyoshi N, Tokunaga O, Sugawara K, Mizokami H, Kimoto M. Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. J Exp Med 1998; 187:1029-1035.
34. Walker FJ, Fay PJ. Regulation of blood coagulation by protein C system. FASEB J 1992; 6:2561-2567.
35. Kohler J, Kasper J, Witt I, Reutern GM. Ischemic stroke due to protein C deficiency. Stroke 1990; 21:1077-1080.
36. Wijnen van M, Stam JG, van't Veer C, Meijers JC, Reitsma PH, Bertina RM, Bouma BN. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S. Thromb Haemost 1996; 76:397-403.
37. Sato Y, Asada Y, Marutsuka K, Hatakeyama K, Sumiyoshi A. Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb Haemost 1996; 75:389-392.
38. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa and protein S as mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 1992, 89:2317-2320.
39. McNamara CA, Sarenbock IJ, Gimple LW, Fenton JW, Coughlin SR, Owens GK. Thrombin stimulates proliferation of aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91:94-98.
40. Sato Y, Asada Y, Marutsuka K, Hatakeyama K, Kamikubo Y, Sumiyoshi A. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb Haemost 1997; 78:1138-1141.
41. Hinsbergh van VWM, Bertina RM, van Wijngaarden A, van Tilburg NH, Emeis JJ, Haverkate F. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 1985; 65:444-451.
42. Xiaoli M, Wenying H, Mingpeng S. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation. Int J Cardiol 1998; 66(Suppl 1):S57-S64.